Press Releases
3 hours ago
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
Indeterminate
GlobeNewswire, Inc.
Apr. 15, 2026
BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026
Indeterminate
GlobeNewswire, Inc.
Apr. 15, 2026
Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe
Indeterminate
GlobeNewswire, Inc.
Apr. 13, 2026
Health Experts Highlight 7 Reasons Seniors Should Stay Active
Neutral
EIN Presswire
Apr. 14, 2026
Digital Health Monitoring Devices Market Size to Reach USD 35.12B by 2035 from USD 7.40B in 2026 (CAGR 18.90%)
Indeterminate
GlobeNewswire, Inc.
Apr. 14, 2026
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
Indeterminate
GlobeNewswire, Inc.
10 hours ago
Landmark Lancet Study Demonstrates Safety and Efficacy of Magnetic Seizure Therapy in Depression
Neutral
EIN Presswire
14 hours ago
New Nordic white paper reveals systemic barriers preventing women from reaching leadership roles
Indeterminate
GlobeNewswire, Inc.
Apr. 8, 2026
Ascendis Pharma to List Ordinary Shares Directly on Nasdaq
Indeterminate
GlobeNewswire, Inc.
Apr. 16, 2026
Evaxion concludes Annual General Meeting
Indeterminate
GlobeNewswire, Inc.
Apr. 1, 2026
Denmark Launches Lawsuit Against Meta Over Child Mental Health Risks
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 31, 2026
Clinical Advancements in Gene Therapy for Neurological Diseases Market Outlook 2026–2035
Neutral
EIN Presswire
Apr. 16, 2026
Freya Biosciences announces positive Phase 1 first-in-human data with FB301 for IVF-related embryo implantation failure
Indeterminate
GlobeNewswire, Inc.
Mar. 31, 2026
Total number of shares and voting rights in Zealand Pharma as of March 31, 2026
Indeterminate
GlobeNewswire, Inc.
Apr. 1, 2026
Dutch Nonprofit Files Lawsuit Against Meta for Child Mental Health Risks
Indeterminate
MENAFN
Owner: Sawsan Dababneh